Related Experiment Video
Updated: Jun 20, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
The relationship between the cardiometabolic syndrome and coronary artery calcium progression
Allen J Taylor1, Holly Wu, Jody Bindeman
1Department of Medicine and Cardiology Service, Walter Reed Army Medical Center, Washington, DC, USA. allen.taylor@medstar.net
Insights
Cardiometabolic syndrome is linked to faster progression of coronary artery calcium (CAC) in healthy men. This condition independently predicts significant CAC advancement over four years, highlighting its importance in cardiovascular health.
Area of Science:
- Cardiology
- Metabolic Health
Background:
- Cardiometabolic syndrome is linked to increased coronary artery calcium (CAC) extent.
- Understanding CAC progression is crucial for cardiovascular risk assessment.
Purpose of the Study:
- To examine the relationship between cardiometabolic syndrome and CAC progression.
- To identify predictors of clinically significant CAC progression.
Main Methods:
- Prospective study of 200 healthy men.
- Repeated electron beam tomography over 4.2 years.
- Multivariable logistic regression and principal component analysis.
Main Results:
- Clinically significant CAC progression (>=15% per year) occurred in 52.5% of participants.
- Cardiometabolic syndrome was more prevalent in those with significant CAC progression (24.8% vs 11.6%, P=.016).
- Cardiometabolic syndrome independently predicted significant CAC progression (OR, 2.65; P=.022).
Conclusions:
- Cardiometabolic syndrome is associated with baseline CAC scores.
- Cardiometabolic syndrome is an independent predictor of CAC progression over four years.
Abstract:
J Clin Hypertens (Greenwich). 2009;11:505-511. (c)2009 Wiley Periodicals, Inc.Cardiometabolic syndrome has been associated with increased likelihood and extent of coronary artery calcium (CAC). The authors examined the relationship of cardiometabolic syndrome to CAC progression in 200 healthy men who volunteered to undergo repeated electron beam tomography separated by 4.2+/-1.3 years. Prediction of clinically significant CAC progression (>/=15% per year) was evaluated using multivariable logistic regression models and principal component analysis. Clinically significant CAC progression was observed in 52.5% of the cohort, with the mean and median rate of annual progression 41.3% and 18.3%, respectively. The cardiometabolic syndrome in clinically significant CAC progression participants was significantly higher compared with those without CAC progression (24.8% vs 11.6%; P=.016). Cardiometabolic syndrome was a significant independent predictor of clinically significant CAC progression (odds ratio, 2.65; P=.022). Cardiometabolic syndrome is associated with the baseline CAC score, and independently associated with the progression of CAC over 4 years.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
